// App-Quantinova.ai

SAT0593 (2018) : Progressive fibrosing interstitial lung disease (PF-ILD in patients with autoimmune rheumatic diseases

Researchers

Presenter

  • A. Fischer

Principal Investigators

  • M. Wijsenbeek

  • M. Kreuter

  • B. Mounir

  • L. Zouad-Lejour

  • V. Acciai

  • C.D. Wells

  • M. Quaresma

  • C. Denton

Medical Centers

  • University of Colorado Hospital, Aurora, CO

  • University Medical Center Rotterdam, Gravendijkwal, Netherlands

  • Universitätsklinikum Heidelberg,Heidelberg,Alemanha

  • Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany,

  • Decision Resources Group, Burlington, MA

  • University College London, London, UK

Locations

  • United States

  • Netherlands

  • South Africa

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Interstitial lung disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved